New study further supports the role of C15:0 in preventing and reversing the alarming rise in liver disease. SAN DIEGO, July 1, 2025 /PRNewswire/ -- A new independent study has revalidated the use of ...

SAN DIEGO — Seraphina Therapeutics, Inc. on May 18 introduced plans to commercialize a saturated fat called pentadecanoic acid, also known as C15:0. The same day Seraphina Therapeutics researchers ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Seraphina Therapeutics has raised $5.5 million in a first funding round, led by Domain Associates, to advance dietary supplements and food fortifiers made from pentadecanoic acid, a trace odd-chain ...

Accurate early diagnosis of acute coronary syndrome (ACS) is a challenging clinical problem. Imaging myocardial fatty acid metabolism with β-methyl-p-[123 I]-iodophenyl-pentadecanoic acid ...